The Facile Game Of Blaming Pharmacy Benefit Managers For High ...

Forbes-11 hours ago

It rightly places the blame for this increase primarily on pharmaceutical manufacturers but wholly overlooks role of Pharmacy Benefit Managers, or PBMs, which ...

Allergan Deal Gets Compounder To Say Drugs Not FDA-OK'd

Allergan Deal Gets Compounder To Say Drugs Not FDA-OK'd

Law360-2 hours ago

Law360 (February 1, 2019, 4:44 PM EST) -- Allergan Inc.'s aggressive bid to block sales of lower-cost compounded drugs has ended with a compounder's ...

An Analysis Of FDA FY2018 Drug GMP Warning Letters

Life Science Leader Magazine-9 hours ago

The term “compounding pharmacy” used here includes outsourcing facilities and is considered a separate category from drug manufacturers based on their ..